Government to issue second licence for medicinal cannabis as demand grows
The Dutch Society of Family Doctors (NHG) maintains there is currently ‘insufficient evidence’ that the drug relieves pain or improves patients’ quality of life
Monday, May 27, 2019
The Dutch government is planning to issue a second licence for the production of medicinal cannabis to meet growing demand patients. The only company authorised to produce cannabis for medical use, Bedrocan in Emmeloord, has increased its output fivefold in the last five years to 2,604 kilograms. Bedrocan received its licence 16 years ago from the Office of Medicinal Cannabis (BMC), which buys the entire stock and distributes it to hospitals and pharmacies. Around half of it is sold abroad to countries including Germany, Italy and Poland. The BMC, established by health minister Els Borst in 2000, is expected to start the European tendering process for a second licence in early June.